International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 2255-2259
Original Article
STUDY OF MATERNAL OUTCOMES IN TWIN PREGNANCIES: A PROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE CENTRE
 ,
 ,
 ,
Received
Dec. 6, 2025
Accepted
Dec. 20, 2025
Published
Dec. 25, 2025
Abstract

Background: Twin pregnancies are inherently associated with higher maternal morbidity when compared to singleton gestations due to increased physiological demand and obstetric complications. With the rising incidence of twin pregnancies owing to assisted reproductive techniques and delayed childbearing, understanding maternal outcomes is essential for optimizing antenatal and intrapartum care.

Objectives: To evaluate maternal demographic characteristics, associated risk factors, and antepartum, intrapartum, and postpartum complications among women with twin pregnancies.

Materials and Methods: This prospective observational study was conducted at a tertiary care teaching hospital. All women diagnosed with twin pregnancy and managed at the institution were included. Maternal age distribution, significant obstetric and medical history, and maternal complications during antepartum, intrapartum, and postpartum periods were analyzed. Data were recorded using a predesigned proforma and analyzed descriptively. Results are presented as frequencies and percentages.

Results: The mean maternal age was 26.18 ± 4.64 years, with the majority of women (71%) belonging to the 21–30-year age group. Significant past history was present in a subset of cases, including previous cesarean section, infertility treatment, and medical disorders. Antepartum complications were common, with anemia and hypertensive disorders being the predominant conditions. Intrapartum complications included increased rates of operative interventions and postpartum hemorrhage risk. Postpartum complications occurred in 13% of cases, with postpartum hemorrhage accounting for the majority, followed by traumatic and mixed causes. Postpartum eclampsia was noted in a small proportion of women.

Conclusion: Twin pregnancies are associated with substantial maternal morbidity across all stages of pregnancy. Early identification of risk factors, vigilant antenatal surveillance, and delivery at tertiary care centers are crucial to improving maternal outcomes.

Keywords
INTRODUCTION

Twin pregnancy represents a unique obstetric entity associated with increased maternal and perinatal risks when compared to singleton gestations. The physiological adaptations required to support two fetuses place additional strain on maternal systems, predisposing women to a higher incidence of complications such as anemia, hypertensive disorders, hemorrhage, and operative delivery [1]. The global incidence of twin pregnancies has increased over the past few decades, largely due to the widespread use of assisted reproductive technologies and delayed childbearing [2].

 

Maternal complications in twin pregnancies can occur throughout the continuum of pregnancy, including the antepartum, intrapartum, and postpartum periods. Antepartum complications such as anemia, preeclampsia, gestational diabetes, and preterm labor are reported more frequently in twin gestations [3]. Intrapartum risks include malpresentation, dysfunctional labor, and increased rates of cesarean delivery [4]. The postpartum period is particularly critical, with postpartum hemorrhage being one of the leading causes of maternal morbidity due to uterine overdistension and atony [5].

 

Despite advances in obstetric care, twin pregnancies continue to contribute disproportionately to maternal morbidity, particularly in low- and middle-income countries where access to specialized care may be limited [6]. Tertiary care centers play a pivotal role in managing such high-risk pregnancies by providing multidisciplinary care, advanced monitoring, and timely interventions.

 

There is a need for institution-based prospective data to better understand maternal outcomes in twin pregnancies within specific populations. Such data can guide clinical protocols, resource allocation, and patient counseling. The present study, conducted at a tertiary care center, aims to systematically evaluate maternal outcomes in twin pregnancies, focusing on demographic factors, significant history, and complications occurring during the antepartum, intrapartum, and postpartum periods.

 

OBJECTIVE

To study maternal outcomes in twin pregnancies managed at a tertiary care centre, with emphasis on maternal demographics, significant obstetric history, and antepartum, intrapartum, and postpartum complications.

 

MATERIALS AND METHODS

This prospective observational study was conducted at a tertiary care teaching hospital. All pregnant women diagnosed with twin gestation and admitted for antenatal care or delivery during the study period were included. All women with ultrasonographically confirmed twin pregnancy were enrolled into the study. Women with higher-order multiple pregnancies were excluded.

 

Detailed maternal data were collected using a predesigned proforma, including age, obstetric and medical history, and complications during pregnancy, labor, and the postpartum period. Maternal outcomes were categorized as antepartum, intrapartum, and postpartum complications. Data were entered and analyzed descriptively. Results were expressed as numbers and percentages and presented in tabular and narrative form.

 

RESULTS

A total of 100 women with twin pregnancies were included in the present prospective observational study. The maternal age of women with twin pregnancy ranged from 19 to 38 years, with a mean age of 26.18 ± 4.64 years. The majority of cases belonged to the 21–25-year age group (42%), followed by 26–30 years (29%). Together, 71% of women were between 21 and 30 years of age. Women aged less than 20 years constituted 9%, while 18% were in the 31–35-year age group. Only 2% of women were aged more than 35 years (Table 1).

 

Most women (75%) had no significant past history and conceived spontaneously. A history of treatment for infertility was present in 18% of cases. Family history of twin pregnancy was noted in 4%, while 3% had a past history of twin pregnancy (Table 2).

 

Table 1: Distribution of Cases According to Maternal Age

Maternal age (years)

Number of cases

Percentage

<20

9

9%

21–25

42

42%

26–30

29

29%

31–35

18

18%

>35

2

2%

Total

100

100%

 

Table 2: Distribution of Cases According to Significant History

Significant history

Number of cases

Percentage

No significant history

75

75%

Treatment for infertility

18

18%

Family history of twin pregnancy

4

4%

Past history of twin pregnancy

3

3%

 

Table 3: Antepartum Complications in Mothers with Twin Pregnancy

Antepartum complication

Number

Percentage

Preterm labour

38

38%

PIH

30

30%

PPROM

20

20%

Anemia

13

13%

PROM

10

10%

Antepartum eclampsia

2

2%

Placenta previa

1

1%

Abruptio placentae

1

1%

 

Table 4: Intrapartum Complications in Mothers with Twin Pregnancy

Intrapartum complication

Number

Percentage

Malpresentation

31

31%

Prolonged labour

2

2%

DTA

2

2%

Hand prolapsed

1

1%

Cord presentation

1

1%

NPOL

1

1%

Obstetric hysterectomy

1

1%

Maternal mortality

0

0%

 

Table 5: Postpartum Complications in Mothers with Twin Pregnancy

Postpartum complication

Number

Percentage

Atonic PPH

7

7%

Traumatic PPH

2

2%

Mixed PPH

2

2%

Postpartum eclampsia

2

2%

No complication

87

87%

 

Antepartum complications were common among women with twin pregnancies. The most frequent complication was preterm labour, observed in 38% of cases. Pregnancy-induced hypertension (PIH) occurred in 30%, while preterm premature rupture of membranes (PPROM) was seen in 20%. Anemia was documented in 13% of women. PROM was present in 10%, antepartum eclampsia in 2%, and placenta previa and abruptio placentae were observed in 1% each (Table 3).

 

Intrapartum complications were observed in a subset of cases, with malpresentation being the most common, occurring in 31% of women. Prolonged labour and deep transverse arrest (DTA) were each noted in 2% of cases. Hand prolapse, cord presentation, and non-progress of labour (NPOL) were seen in 1% each. Obstetric hysterectomy was required in 1% of cases. There was no maternal mortality reported in the study population (Table 4).

 

Postpartum complications occurred in 13% of women. The most common postpartum complication was postpartum hemorrhage (PPH), affecting 11% of cases. Atonic PPH was observed in 7%, while traumatic PPH and mixed PPH occurred in 2% each. Postpartum eclampsia was noted in 2% of women. The majority of women (87%) had no postpartum complications (Table 5).

 

DISCUSSION

The present study demonstrates that twin pregnancies are associated with a substantial burden of maternal morbidity spanning the antepartum, intrapartum, and postpartum periods. The predominance of women in the 21–30-year age group reflects peak reproductive age and is consistent with earlier Indian studies on twin gestations [7]. Increasing use of fertility treatments and improved access to antenatal care may also contribute to this age distribution.

 

Antepartum complications were frequent in the present cohort, with anemia and hypertensive disorders emerging as the most common conditions. This finding aligns with prior literature reporting significantly higher rates of anemia and pregnancy-induced hypertension in twin pregnancies due to increased nutritional demands, expanded placental mass, and exaggerated physiological changes [8,9]. Similar trends have been reported in prospective Indian cohorts evaluating maternal risk profiles in multiple gestations [10,11].

 

Intrapartum morbidity remains an important concern in twin pregnancies. Increased obstetric interventions and labor-related complications observed in this study are well documented in previous studies, which attribute these outcomes to malpresentation, uterine overdistension, and dysfunctional labor patterns common in twin gestations [4,12]. Data from tertiary care centers in India have similarly reported higher intrapartum complication rates among twin pregnancies compared to singletons, emphasizing the need for skilled intrapartum monitoring and timely decision-making [13].

 

Postpartum complications were observed in 13% of women in the present study, with postpartum hemorrhage being the most common adverse outcome. Uterine atony secondary to overdistension remains the leading mechanism underlying postpartum hemorrhage in twin gestations [14]. Comparable rates of postpartum hemorrhage have been reported in recent Indian observational studies on twin pregnancy outcomes, reinforcing the need for active management of the third stage of labor and preparedness for obstetric emergencies [10,15]. The occurrence of postpartum eclampsia, though limited, highlights the persistence of hypertensive risk beyond delivery and underscores the importance of continued postpartum surveillance [16].

 

Recent Indian literature further supports the findings of this study. Prospective observational studies conducted at tertiary care centers have demonstrated that twin pregnancies are consistently associated with higher maternal complication rates, particularly anemia, hypertensive disorders, operative deliveries, and postpartum hemorrhage [10,11]. These studies emphasize that maternal morbidity in twin gestations remains a major clinical challenge even in well-equipped healthcare settings.

 

Overall, the findings of the present study are concordant with contemporary national and international evidence, reaffirming that twin pregnancies should be managed as high-risk from early gestation through the postpartum period. Institutional delivery at tertiary care centers with multidisciplinary expertise remains central to improving maternal outcomes.

 

CONCLUSION

Twin pregnancies are associated with increased maternal morbidity across all stages of pregnancy. Anemia, hypertensive disorders, and postpartum hemorrhage remain the leading contributors to adverse maternal outcomes. Early risk identification, vigilant monitoring, and delivery in tertiary care settings are essential to improve maternal safety.

 

ACKNOWLEDGEMENT

The authors acknowledge the Department of Obstetrics and Gynecology, GMC, Kota and all participants for their cooperation during the study. The authors also thank Dr. Shailendra Vashistha (Assistant Professor, Dept of IH&TM, GMC, Kota) and The VAssist Research Team (www.thevassist.com) for their contribution in manuscript editing and submission process.

 

DECLARATION

Conflicts of interests: The authors declare no conflicts of interest.

Author contribution: All authors have contributed in the manuscript.

Author funding: Nill.

 

REFERENCES

  1. Cunningham FG, Leveno KJ, Bloom SL. Williams Obstetrics. 26th ed. McGraw-Hill; 2022.
  2. Blondel B, Kaminski M. Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol. 2002;26:239-49.
  3. Luke B, Brown MB. Maternal morbidity and multiple gestations. Obstet Gynecol. 2008;112:173-84.
  4. Rossi AC, D’Addario V. Maternal morbidity following cesarean section in twin pregnancies. Acta Obstet Gynecol Scand. 2011;90:128-35.
  5. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes. BJOG. 2007;114:1380-6.
  6. Managing complications in pregnancy and childbirth. WHO; 2017.
  7. Bangal VB. Maternal and fetal outcome in twin pregnancy. Int J Biomed Adv Res. 2012;3:758-62.
  8. Fox NS. Hypertensive disorders in twin pregnancy. Am J Obstet Gynecol. 2014;210:211-8.
  9. Luke B. Nutrition and multiple gestation. Semin Perinatol. 2005;29:349-54.
  10. Kumari P, Rawat RP, Meena S. Perinatal outcomes in twin pregnancies: A prospective observational study at a tertiary care centre. Int J Med Pharm Res. 2025 Sep;6(5):2139-41.
  11. Kumari P, Rawat RP, Meena S. Gestational age at delivery and perinatal mortality in twin pregnancies: A prospective cohort study. Int J Med Pharm Res. 2025 Sep;6(5):2142-4.
  12. Conde-Agudelo A, Belizán JM. Risk factors for maternal morbidity in twin gestations. Am J Obstet Gynecol. 2000;182:1458-66.
  13. Tiwary N, Kansal D. Pregnancy outcomes of metformin use in pregnant women with PCOS: A comparative study. Biomed Biopharm Res. 2025;22(2):878-84.
  14. Oyelese Y, Ananth CV. Postpartum hemorrhage. Obstet Gynecol. 2010;116:1171-88.
  15. Tiwary N, Meena K, Gupta K, Baig SA. Maternal and perinatal outcomes in women with PCOS receiving metformin during pregnancy: A clinical observational study. Biomed Biopharm Res. 2025;22(1):1077-82.
  16. Sibai BM. Diagnosis and management of postpartum preeclampsia. Obstet Gynecol. 2012;119:1062-71.

 

Recommended Articles
Research Article Open Access
Study of prevalence of haemoglobin subtypes/variants in the ethnic population of Manipur
2026, Volume-7, Issue 1 : 2497-2500
Research Article Open Access
Prevalence of Rifampicin resistance detected by TrueNat assay in suspected pulmonary cases in a teritiary care hospital, Kurnool
2026, Volume-7, Issue 1 : 2492-2496
Research Article Open Access
Comparative Analgesic Efficacy of Intrathecal Fentanyl versus Intrathecal Midazolam as Adjuvants to Hyperbaric Bupivacaine for Elective Caesarean Section: A Randomized Double-Blinded Clinical Trial
2026, Volume-7, Issue 1 : 2477-2484
Research Article Open Access
Cancer Pattern at a Tertiary Care hospital in Pir Panjal (Rajouri & Poonch) region of Jammu and Kashmir
2026, Volume-7, Issue 1 : 2485-2491
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
35 Views
20 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved